Gastrointestinal and Other Cancers Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis | Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin, Placebo Administration | NCT02743364 | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Questionnaire Administration, Simvastatin, Placebo Administration | NCT02968810 | National Cancer Institute (NCI) | Recruiting |
| Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Therapeutic Conventional Surgery | NCT00118040 | National Cancer Institute (NCI) | Active, not recruiting |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... | Erlotinib Hydrochloride, Erlotinib | NCT02961374 | National Cancer Institute (NCI) | Active, not recruiting |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib | NCT02273362 | National Cancer Institute (NCI) | Active, not recruiting |
| Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers | Laboratory Biomarker Analysis, Questionnaire Administration, Dolcanatide, Placebo Administration | NCT03300570 | National Cancer Institute (NCI) | Active, not recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | NCT02772003 | National Cancer Institute (NCI) | Active, not recruiting |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis | Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration | NCT03278925 | National Cancer Institute (NCI) | Recruiting |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... | Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration | NCT02782949 | National Cancer Institute (NCI) | Active, not recruiting |